Brands seek to meet consumer needs, even as regulatory uncertainty challenges broad market expansion.
December 17, 2020
The COVID-19 pandemic has wreaked havoc around the globe, separating families, plunging nations into economic distress and exacerbating underlying health issues. It's no wonder consumers are reporting higher levels of insomnia, stress and anxiety—and accelerated interest in CBD products. Market data supports information about new consumer usage, and consistent interest in CBD for its sleep, relaxation and health management abilities. Covered in this CBD report:
Assessing CBD in Europe and identifying key restrictions hindering market growth
The evolution of delivery formats and addressing bioavailability
Clinical research substantiating health effects and efficacy
Regulatory update on the status of CBD in Europe and what this means for brands
Tapping into a restricted market that continues to draw consumer interest
Underwritten by:
Read more about:
Reports
